Hangzhou Minsheng Healthcare Co., Ltd. (SHE:301507)
China · Delayed Price · Currency is CNY 11.84
+0.12 (1.02%)
At close: Sep 14, 2026
SHE:301507 Revenue
Hangzhou Minsheng Healthcare had revenue of 217.87M CNY in the quarter ending June 30, 2026, with 14.06% growth. This brings the company's revenue in the last twelve months to 854.51M, up 20.98% year-over-year. In the year 2025, Hangzhou Minsheng Healthcare had annual revenue of 781.63M with 21.89% growth.
Revenue (ttm)
854.51M
Revenue Growth
+20.98%
P/S Ratio
4.86
Revenue / Employee
n/a
Employees
710
Market Cap
4.15B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 781.63M | 140.38M | 21.89% |
| Dec 31, 2024 | 641.25M | 59.52M | 10.23% |
| Dec 31, 2023 | 581.73M | 34.61M | 6.33% |
| Jan 1, 2023 | 547.12M | 57.54M | 11.75% |
| Dec 31, 2021 | 489.58M | 50.15M | 11.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.82B |
| Zhejiang Int'l Group | 34.20B |
| Zhejiang Zhenyuan Share | 1.86B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.84B |
| GuangYuYuan Chinese Herbal Medicine | 1.41B |
| Chongqing Lummy Pharmaceutical | 748.94M |
| Hangzhou Bio-Sincerity Pharma-Tech | 709.72M |
| Hubei Guangji Pharmaceutical | 651.57M |